BR0013840A - Análogos monoméricos de insulina humana - Google Patents
Análogos monoméricos de insulina humanaInfo
- Publication number
- BR0013840A BR0013840A BR0013840-1A BR0013840A BR0013840A BR 0013840 A BR0013840 A BR 0013840A BR 0013840 A BR0013840 A BR 0013840A BR 0013840 A BR0013840 A BR 0013840A
- Authority
- BR
- Brazil
- Prior art keywords
- human insulin
- monomeric
- monomeric analogues
- analogues
- human
- Prior art date
Links
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title abstract 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"ANáLOGOS MONOMéRICOS DE INSULINA HUMANA". Análogos monoméricos de insulina humana têm uma única substituição do aminoácido na 12<198>, 16<198> e 26<198> posição da cadeia B da insulina humana e também podem ter uma eliminação terminal na cadeia B.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99116851A CN1125081C (zh) | 1999-09-08 | 1999-09-08 | 重组天然和新型人胰岛素及其制备方法 |
| PCT/GB2000/003460 WO2001018052A1 (en) | 1999-09-08 | 2000-09-08 | Monomeric analogues of human insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0013840A true BR0013840A (pt) | 2002-07-02 |
Family
ID=5279521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0013840-1A BR0013840A (pt) | 1999-09-08 | 2000-09-08 | Análogos monoméricos de insulina humana |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6800606B1 (pt) |
| EP (1) | EP1210369A1 (pt) |
| JP (1) | JP2003525867A (pt) |
| CN (1) | CN1125081C (pt) |
| AU (1) | AU767006B2 (pt) |
| BR (1) | BR0013840A (pt) |
| CA (1) | CA2383638A1 (pt) |
| CZ (1) | CZ20021227A3 (pt) |
| HU (1) | HUP0202793A3 (pt) |
| IL (1) | IL148380A0 (pt) |
| MX (1) | MXPA02002489A (pt) |
| NO (1) | NO20021135L (pt) |
| PL (1) | PL354488A1 (pt) |
| TR (1) | TR200200599T2 (pt) |
| WO (1) | WO2001018052A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR025646A1 (es) * | 2000-09-13 | 2002-12-04 | Beta Lab Sa | Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa. |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| US9388227B2 (en) | 2012-03-29 | 2016-07-12 | Biocon Limited | Process of expressing a fully folded functional two chain insulin glargine |
| CN102703552B (zh) * | 2012-05-15 | 2014-10-29 | 山东阿华生物药业有限公司 | 重组人胰岛素的制备方法及其产品 |
| CN102816819B (zh) * | 2012-08-13 | 2014-10-29 | 山东阿华生物药业有限公司 | 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法 |
| DK3551209T3 (da) * | 2016-12-09 | 2021-08-23 | Akston Biosciences Corp | Insulin-fc-fusioner og fremgangsmåder til anvendelse |
| JP7457023B2 (ja) | 2018-08-20 | 2024-03-27 | バイオコン バイオロジクス リミテッド | インスリンアナログの精製のためのクロマトグラフィープロセス |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3033127A1 (de) * | 1980-09-03 | 1982-04-08 | Hoechst Ag, 6000 Frankfurt | Neue analoga des insulins |
| DK58285D0 (da) | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DE3717370A1 (de) | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
| PT93057B (pt) * | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
| WO1994014461A1 (en) * | 1992-12-18 | 1994-07-07 | Eli Lilly And Company | Insulin analogs |
| CN1044856C (zh) | 1993-10-19 | 1999-09-01 | 中国科学院上海有机化学研究所 | 果聚糖同系混合物的药物、生产方法及其用途 |
| AR002976A1 (es) | 1995-03-31 | 1998-05-27 | Lilly Co Eli | Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas |
| ID26788A (id) * | 1998-02-23 | 2001-02-08 | Neurocrine Biosciences Inc | Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin |
-
1999
- 1999-09-08 CN CN99116851A patent/CN1125081C/zh not_active Expired - Fee Related
-
2000
- 2000-09-08 MX MXPA02002489A patent/MXPA02002489A/es active IP Right Grant
- 2000-09-08 WO PCT/GB2000/003460 patent/WO2001018052A1/en active IP Right Grant
- 2000-09-08 US US10/070,568 patent/US6800606B1/en not_active Expired - Fee Related
- 2000-09-08 CA CA002383638A patent/CA2383638A1/en not_active Abandoned
- 2000-09-08 TR TR2002/00599T patent/TR200200599T2/xx unknown
- 2000-09-08 EP EP00962653A patent/EP1210369A1/en not_active Withdrawn
- 2000-09-08 AU AU74305/00A patent/AU767006B2/en not_active Ceased
- 2000-09-08 PL PL00354488A patent/PL354488A1/xx not_active Application Discontinuation
- 2000-09-08 JP JP2001522274A patent/JP2003525867A/ja active Pending
- 2000-09-08 IL IL14838000A patent/IL148380A0/xx unknown
- 2000-09-08 BR BR0013840-1A patent/BR0013840A/pt not_active Application Discontinuation
- 2000-09-08 CZ CZ20021227A patent/CZ20021227A3/cs unknown
- 2000-09-08 HU HU0202793A patent/HUP0202793A3/hu unknown
-
2002
- 2002-03-07 NO NO20021135A patent/NO20021135L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1210369A1 (en) | 2002-06-05 |
| AU7430500A (en) | 2001-04-10 |
| MXPA02002489A (es) | 2002-08-28 |
| WO2001018052A1 (en) | 2001-03-15 |
| CN1287124A (zh) | 2001-03-14 |
| JP2003525867A (ja) | 2003-09-02 |
| CA2383638A1 (en) | 2001-03-15 |
| PL354488A1 (en) | 2004-01-26 |
| NO20021135D0 (no) | 2002-03-07 |
| US6800606B1 (en) | 2004-10-05 |
| CZ20021227A3 (cs) | 2002-07-17 |
| HUP0202793A3 (en) | 2005-07-28 |
| IL148380A0 (en) | 2002-09-12 |
| NO20021135L (no) | 2002-03-07 |
| CN1125081C (zh) | 2003-10-22 |
| TR200200599T2 (tr) | 2002-05-21 |
| HUP0202793A2 (hu) | 2002-12-28 |
| AU767006B2 (en) | 2003-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| BR0209434A (pt) | Peptìdeos antimicrobianos e composições | |
| EA200400067A1 (ru) | Конъюгаты гксф | |
| UY24572A1 (es) | Conjugados peg - interferon alfa | |
| BR9809304A (pt) | "formulações de proteìna c ativada" | |
| HK1046134A1 (en) | Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them. | |
| BR9810478A (pt) | Análogos de hormÈnio glicoproteìna reticulados por dissulfeto e sua preparação e utilização | |
| NO974321L (no) | Nodulisporsyrederivater | |
| UA32523C2 (uk) | Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі | |
| CY1106633T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c | |
| DE3780000D1 (de) | Peptidverbindungen. | |
| BR0013840A (pt) | Análogos monoméricos de insulina humana | |
| DK1124797T3 (da) | N-Arylsulfonyl-aminosyre-omega-amider | |
| ATE339201T1 (de) | Lasofoxifen enthaltende zusammensetzungen | |
| BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
| EA199900479A1 (ru) | Стабилизированные фармацевтические композиции на основе хинупристина и дальфопристина и способ получения | |
| AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
| DE69005241D1 (de) | Calcitonin enthaltende pharmazeutische Zusammensetzungen. | |
| DK0931082T3 (da) | Nodulisporinsyrederivater | |
| DE59009765D1 (de) | Säuremodifizierte Polyarylensulfide. | |
| DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| BR9809286A (pt) | Processos para redução de fibrinogênio | |
| AR004088A1 (es) | Gonadotropinas compuestas por una subunidad alfa y una subunidad beta | |
| ES2091571T3 (es) | Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| BR9912183A (pt) | Receptor de angiotensina, preparação e aplicação do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |